CRIS
Permanent URI for this communityhttps://scripta.up.edu.mx/handle/20.500.12552/1
Browse
3 results
Search Results
Now showing 1 - 3 of 3
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Risk Factors Associated with Diabetic Retinopathy with and without Macular Edema in Recently Diagnosed Patients with Type 2 Diabetes(Taylor and Francis Group, 2024) ;García-Ulloa, Ana ;Pérez-Peralta, Liliana ;Jaime-Casas, Salvador ;Jiménez-Corona, AidaRivera-De La Parra, DavidPurpose: To evaluate the risk factors associated with diabetic macular edema (DME) in patients with a recent type 2 diabetes mellitus (T2DM) diagnosis. Patients and Methods: We conducted a case-control study at a third-level hospital in Mexico City. We enrolled patients ≥18 years old, with T2DM less than five years of diagnosis, without disabling complications, and non-smokers. The control group was patients with diabetic retinopathy and without macular edema (DR-DME). Cases were patients with DR+DME. We measured fasting glucose, creatinine, lipid profile, urinary albumin/creatinine ratio (ACR), and HbA1c. An ophthalmological examination consisted of visual acuity measurement, digital three-field fundus photography with an automatic non-mydriatic camera, slit lamp, and Optical coherence tomography (OCT) examination ©Dove Press14 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, De-escalating treatment indications for patients who achieve metabolic goals(Elsevier, 2024) ;García-Ulloa, Ana Cristina ;Jaime-Casas, Salvador ;Rosado-Lozoya, Johanna S. ;Serrano-Pérez, Nancy H.Hernández-Juárez, DianaIntroduction: Robust evidence exists regarding initiation, intensification or modification of treatments. Recommendations to de-escalate therapy are lacking, specifically in diabetes. A successful treatment de-intensification reduces overtreatment, polypharmacy, and risk of adverse effects. Objective: To encompass current recommendations for deprescribing common drugs and create a consensus among health professionals. Methods: We reviewed four databases for deprescribing approaches published between 2010 and 2022. Articles were divided into different groups of drugs (for uric-acid, hypoglycemic, lipid-lowering, and psychotropic drugs).©Elsevier16 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Overview and characterization of penile cancer content across social media platforms(Frontiers Media, 2023) ;Ortiz-Guerra, Ruben Alejandro ;Jaime-Casas, Salvador ;Martinez-Cannon, Bertha Alejandra ;Ariza-Avila, Jose C.González-Morales, Ana P.Background: Social media platforms (SMP) are an emerging resource that allows physicians, patients, and families to converse on cancer prevention, diagnosis, and treatment. We aimed to characterize penile cancer (PC) content shared on SMP. Methods: We searched PC posts on Twitter, Facebook, and Instagram from July 1st, 2021, through June 30th, 2022. Two independent, blinded reviewers analyzed the hashtags: #PenileCancer, #PenileCancerAwareness, and #PenileNeoplasm. Descriptive statistics were used for posts characterization, Pearson´s correlation coefficient for associations, and Cohen’s weighted kappa coefficient for inter-rater agreement rate. ©Frontiers Media18 1
